# B-pVAC-SARS-CoV-2: Study to Prevent COVID-19 Infection in Adults With Bcell/ Antibody Deficiency

> **NCT04954469** · PHASE1,PHASE2 · COMPLETED · sponsor: **University Hospital Tuebingen** · enrollment: 54 (actual)

## Conditions studied

- Immune Deficiency Disease

## Interventions

- **BIOLOGICAL:** CoVAC-1

## Key facts

- **NCT ID:** NCT04954469
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-30
- **Primary completion:** 2022-08-18
- **Final completion:** 2023-04-30
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2023-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04954469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04954469, "B-pVAC-SARS-CoV-2: Study to Prevent COVID-19 Infection in Adults With Bcell/ Antibody Deficiency". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04954469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*